158 related articles for article (PubMed ID: 6088634)
21. Blastogenic response of human lymphocytes to human cytomegalovirus.
Waner JL; Budnick JE
Clin Exp Immunol; 1977 Oct; 30(1):44-9. PubMed ID: 203423
[TBL] [Abstract][Full Text] [Related]
22. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
[TBL] [Abstract][Full Text] [Related]
23. Human monoclonal antibodies recognize early and late viral proteins of human cytomegalovirus.
Alexander H; Harpprecht J; Podzuweit HG; Rautenberg P; Müller-Ruchholtz W
Hum Antibodies Hybridomas; 1994; 5(1-2):81-90. PubMed ID: 7858186
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies: methods and clinical laboratory applications.
Nakamura RM
Clin Physiol Biochem; 1983; 1(2-5):160-72. PubMed ID: 6396016
[TBL] [Abstract][Full Text] [Related]
25. [A strategy for the production of human monoclonal antibodies].
Chiba J
Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441
[TBL] [Abstract][Full Text] [Related]
26. [Attempts to improve hybridoma technology for the production of human monoclonal antibodies].
Tokunaga T; Chiba J; Ohnishi K
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2198-204. PubMed ID: 3038035
[TBL] [Abstract][Full Text] [Related]
27. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
Cote RJ; Morrissey DM; Oettgen HF; Old LJ
Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
[TBL] [Abstract][Full Text] [Related]
28. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
Fletcher JM; Prentice HG; Grundy JE
J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
[TBL] [Abstract][Full Text] [Related]
29. [Preparation of monoclonal antibodies to super early human cytomegalovirus proteins and their use for detecting infected cells].
Makarova NE; Kushch AA; Ivanova LA; Martynova VN; Barinskiĭ IF; Pustowoit B
Vopr Virusol; 1996; 41(1):28-32. PubMed ID: 8669143
[TBL] [Abstract][Full Text] [Related]
30. An enzyme immunoassay based micro-neutralization test for titration of antibodies to human cytomegalovirus (CMV) and its correlation with direct ELISA measuring CMV IgG antibodies.
Gupta CK; Leszczynski J; Gupta RK; Siber GR
Biologicals; 1996 Mar; 24(1):41-9. PubMed ID: 8733600
[TBL] [Abstract][Full Text] [Related]
31. Reconstitution of cytomegalovirus specific T cells after pediatric allogeneic stem cell transplantation: results from a pilot study using a multi-allele CMV tetramer group.
Koehl U; Dirkwinkel E; Koenig M; Erben S; Soerensen J; Bader P; Doerr HW; Preiser W; Weissinger E; Klingebiel T; Martin H; Lehrnbecher T
Klin Padiatr; 2008; 220(6):348-52. PubMed ID: 18949669
[TBL] [Abstract][Full Text] [Related]
32. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
[TBL] [Abstract][Full Text] [Related]
33. [Monoclonal antibodies produced by human-human hybridomas].
Chida J
Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
[TBL] [Abstract][Full Text] [Related]
34. Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cells.
Paine A; Oelke M; Blasczyk R; Eiz-Vesper B
Transfusion; 2007 Nov; 47(11):2143-52. PubMed ID: 17958544
[TBL] [Abstract][Full Text] [Related]
35. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization.
Strike LE; Devens BH; Lundak RL
J Immunol; 1984 Apr; 132(4):1798-803. PubMed ID: 6699402
[TBL] [Abstract][Full Text] [Related]
36. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
38. Human monoclonals against erythrocyte antigens.
Ernst M; Sonneborn HH
Hum Antibodies Hybridomas; 1990; 1(3):122-5. PubMed ID: 1966475
[TBL] [Abstract][Full Text] [Related]
39. Incorporation of T cell counterparts in the fusion partners for generation of human monoclonal antibodies from Staphylococcus aureus stimulated B lymphocytes.
Gore MM; Singhania SS; Basu A; Banerjee K
Hum Antibodies; 1997; 8(1):26-32. PubMed ID: 9265502
[TBL] [Abstract][Full Text] [Related]
40. Antibody production of a human EBV-transformed B cell line and its heterohybridoma and trioma cell line descendants in different culture systems.
Gustafsson B; Hinkula J
Hum Antibodies Hybridomas; 1994; 5(3-4):98-104. PubMed ID: 7756584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]